Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

BACKGROUND: Many peptide-based cancer vaccines have been tested in clinical trials with a limited success, mostly due to difficulties associated with peptide stability and delivery, resulting in inefficient antigen presentation. Therefore, the development of suitable and efficient vaccine carrier sy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ma, Wenxue, Smith, Trevor, Bogin, Vladimir, Zhang, Yu, Ozkan, Cengiz, Ozkan, Mihri, Hayden, Melanie, Schroter, Stephanie, Carrier, Ewa, Messmer, Davorka, Kumar, Vipin, Minev, Boris
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2011
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3078865/
https://ncbi.nlm.nih.gov/pubmed/21450109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-34
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg